Enterprise League logo
Products

OGSIVEO® (nirogacestat) | SpringWorks Therapeutics

Product description

OGSIVEO® (nirogacestat) is a gamma secretase inhibitor approved for the treatment of adults with desmoid tumors and for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN).

SpringWorks Therapeutics Logo

SpringWorks Therapeutics

Stamford, United States (US)


Price: N/A